quipazine has been researched along with quinoline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bach, A; Bucciarelli, S; Gotfredsen, CH; Høj, LJ; Langkilde, AE; Meier, S; Narayanan, D; Sattler, M; Softley, C; Solbak, SMØ; Zang, J | 1 |
| Anzini, M; Bruni, G; Cappelli, A; De Benedetti, PG; Doucet, E; Hamon, M; Langer, T; Makovec, F; Mennuni, L; Menziani, MC; Romeo, MR; Vomero, S | 1 |
2 other study(ies) available for quipazine and quinoline
| Article | Year |
|---|---|
Developing Inhibitors of the p47phox-p22phox Protein-Protein Interaction by Fragment-Based Drug Discovery.
Topics: Azoles; Drug Discovery; Humans; Indoles; Isoindoles; Molecular Structure; NADPH Oxidase 2; NADPH Oxidases; Organoselenium Compounds; Protein Binding; Structure-Activity Relationship | 2020 |
Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 1. Mapping the central 5-HT3 receptor binding site by arylpiperazine derivatives.
Topics: Animals; Benzene; Binding Sites; Glioma; Guanidine; Mice; Models, Molecular; Molecular Structure; Neuroblastoma; Phenanthridines; Piperazines; Quinolines; Quipazine; Rats; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Serotonin Receptor Agonists; Structure-Activity Relationship; Tumor Cells, Cultured | 1998 |